Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma

UNC Libraries(2020)10.17615/73y8-rn80Source: DataRank Database

Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.51)OA: greenTopics (49)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Gatien Moriceau ORCID,Robert Damoiseaux ORCID,Roger S. Lo ORCID,Lu Sun ORCID,Aayoung Hong ORCID

Live enrichment

PubMed:19767382 OpenAlex:https://openalex.org/W4299350824

National Institutes of Health

Grant: 1P01CA168585-01A1

TARGETED COMBINATORIAL TREATMENT OF BRAF MELANOMAS

National Institutes of Health

Grant: 5R01CA176111-09

Combinatorial Targeting of Epigenomic and Microenvironmental Pathways to Suppress MAPK Inhibitor Resistance in Melanoma

FWCI

0.51

Citation Percentile

0.7%

Citation Trend

2017

2018

2019

2020

2022

2023

greenLicense: http://rightsstatements.org/vocab/InC/1.0/

repositoryhttps://doi.org/10.17615/73y8-rn80

https://doi.org/10.1158/2159-8290.cd-17-0682

https://cdr.lib.unc.edu/downloads/qn59q867f

https://dx.doi.org/10.17615/73y8-rn80

https://pubmed.ncbi.nlm.nih.gov/28923912

Fields of Study

Computational Drug Discovery MethodsMelanoma and MAPK PathwaysReceptor Mechanisms and Signaling0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

AddictionDrugMelanomaComputational biologyDrug resistanceMedicineCancer researchBiologyPharmacologyGeneticsPsychiatrySubstance-Related DisordersOncology and Carcinogenesis610MiceBrain Disorders (rcdc)5.1 Pharmaceuticals (hrcs-rac)616Animals (mesh)3211 Oncology and carcinogenesis (for-2020)AnimalsHumans32 Biomedical and Clinical Sciences (for-2020)3101 Biochemistry and cell biology (for-2020)Protein Kinase InhibitorsCancerCancer (rcdc)Humans (mesh)3 Good Health and Well Being (sdg)Biomedical and Clinical SciencesGenetics (rcdc)Mice (mesh)Protein Kinase Inhibitors (mesh)Substance-Related Disorders (mesh)1112 Oncology and Carcinogenesis (for)Brain DisordersGood Health and Well Being5.1 PharmaceuticalsDrug Resistance, NeoplasmBiochemistry and cell biologyNeoplasmMelanoma (mesh)Neoplasm (mesh)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being